Markets
BSE See NSE See 39,024.77
63.98 (0.16%)
collapse Related Readings collapse

Recommendation Review: Glenmark Pharmaceuticals

| 5/16/2013 9:00 PM Thursday

We had recommended Glenmark Pharma to our readers in DSIJ Vol. 27, Issue # 26 (dated December 16, 2012), when it was trading at a price of Rs 437. Our recommendation was based on the fact it is a consistent performer in the pharma sector and is also witnessing strong growth in its domestic as well as international business. Its strong pipeline of innovative products and the focus on low competition niche products are the main factors that we took into consideration.

The strongest positive for the company is its strong product pipeline. Glenmark has four product approvals in Russia in the dermatology segment. In USA, it has 10 approvals for oral contraceptives (OCs) and 19 approvals for dermatology products. It has already monetised some OCs this year, which are yielding higher revenues. Glenmark has also a presence in Japan, which is the world’s second largest pharma market, and this will benefit the company in the future.

Post our recommendation, the company came out with its Q3 and Q4 financial results, which were fantastic. For Q4, it has reported a 25 per cent increase in its topline to Rs 1335 crore. Its net profit also rose by 11 per cent to touch Rs 166.7 crore. The balance sheet is also in healthy shape, with the debt-to-equity ratio below 1x. We believe that investors should take their money off the table following the fantastic performance of the company. This would give them a 25 per cent return on their investment.

 

Find More Articles on: DSIJ Magazine, Reviews, Stock Recommendations, Fundamental Picks, Product, Large Cap, Mid Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.